DrugPatentWatch Database Preview
Profile for Serbia Patent: 20120340
US Patent Family Members and Approved Drugs for Serbia Patent: 20120340
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | May 15, 2023 | Celgene | POMALYST | pomalidomide |
➤ Try a Free Trial | Nov 24, 2024 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | May 15, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | May 15, 2023 | Celgene | POMALYST | pomalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |